Co-Authors
This is a "connection" page, showing publications co-authored by Ahmed Kandeil and Mohamed GabAllah.
Connection Strength
0.467
-
Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies. Vaccines (Basel). 2021 Mar 03; 9(3).
Score: 0.233
-
Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt. Influenza Other Respir Viruses. 2021 11; 15(6):750-756.
Score: 0.060
-
Sinapic Acid Suppresses SARS CoV-2 Replication by Targeting Its Envelope Protein. Antibiotics (Basel). 2021 Apr 11; 10(4).
Score: 0.059
-
Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort. PLoS Pathog. 2021 03; 17(3):e1009413.
Score: 0.058
-
FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2. Pharmaceuticals (Basel). 2020 Dec 04; 13(12).
Score: 0.057